# Vivos Therapeutics, Inc.: Form 8-K, filed Mar 31, 2025

- Company: [Vivos Therapeutics, Inc.](/companies/vvos.md) (CIK 1716166)
- Form: 8-K
- Filed: 2025-03-31
- Accepted by EDGAR: Mar 31, 2025, 17:29 ET
- Period: 2025-03-31
- Accession: 0001641172-25-001895
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1716166/000164117225001895/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716166/000164117225001895/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716166/000164117225001895/form8-k.htm

Filed Mar 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-001895. Last ingested by Listed: Nov 2, 2026, 06:07 ET. No prices; not investment advice.